This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Tomas Andersson

Vice President, Medical Science Director

I lead a global clinical and medical team in AstraZeneca's Cardiovascular and Metabolic Disease area, and as MSD I am responsible for the benefit risk of the product.

You are viewing: All posts Reset filters

Our Other Authors